A Somatostatin Receptor Subtype-3 (SST3) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary Tumors

Mari C. Vázquez‐Borrego, Raúl M. Luque, Rosa Ortega‐Salas et al.|Clinical Cancer Research|2019

Cited by 52